PICO Portalanswers from OpenAlex & ORCID
Richard J. Gralla
ResearcherPublications, citations & collaboration network
Richard J. Gralla is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Richard J. Gralla have?
PICO Portalindexed works
Richard J. Gralla has 373 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Richard J. Gralla have?
PICO Portalcitation count
Richard J. Gralla has 22,631 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Richard J. Gralla?
PICO Portalh-index
Richard J. Gralla has an h-index of 72 in OpenAlex.
What is the i10-index of Richard J. Gralla?
PICO Portali10-index
Richard J. Gralla has an i10-index of 174 in OpenAlex.
What is the ORCID of Richard J. Gralla?
PICO Portalorcid
The ORCID for Richard J. Gralla is on the source record.
What is the OpenAlex record for Richard J. Gralla?
PICO Portalopenalex
The OpenAlex for Richard J. Gralla is on the source record.
What are the most-cited papers on Richard J. Gralla?
PICO Portalmost cited works
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, K. Mattson, Richard J. Gralla, Mark Allen O’Rourke, Nathan Levitan, Laurent Gressot, Mark Vincent, Ronald L. Burkes, Susan Coughlin, Yong Kim, J. Bérille
Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
Chee Khoon Lee, Chris Brown, Richard J. Gralla, Vera Hirsh, Sumitra Thongprasert, Chun‐Ming Tsai, Eng Huat Tan, Jcm Ho, D. Chu, Adel Zaatar, Jemela Anne Osorio Sanchez, Vu Van Vu, Joseph S. K. Au, Akira Inoue, Siow Ming Lee, Val Gebski, James Chih‐Hsin Yang
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
Paul J. Hesketh, Antônio Rossi, Giada Rizzi, Marco Palmas, Anna Alyasova, Igor Bondarenko, Alla Lisyanskaya, Richard J. Gralla